← Russell 3000 cross-section

TLRY Tilray Brands, Inc.

Trailing twelve months to 2026-05-31 · as filed 2026-07-28, not restated
Healthcare

Scale

Market cap
$635m
Revenue TTM
$916m
Net income TTM
$-121m
Free cash flow
Composite score
Sector rank
#2284

Valuation

P / E
EV / EBITDA
EV / sales
0.5
FCF yield
Earnings yield vs 10-yr
-23.85pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-13.3%
EBITDA margin
ROE
-7.5%
ROIC
-4.5%
Revenue growth
11.5%

Insider activity, last 90 days

Net open-market
$0.07m
Buyers
3
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Our overall strategy is to leverage our brands, infrastructure, expertise and capabilities to drive revenue growth in the industries in which we compete, achieve industry-leading profitability and build sustainable, long-term shareholder value. Fractional shares resulting from the Reverse Stock Split were rounded down to the nearest whole share and stockholders received cash in lieu of any fractional shares that were created by the Reverse Stock Split, see Note 14 (Stockholder’s equity) for additional details. …Tilray Brands, Inc., 10-Q, period ended 2026-02-28, filed 2026-04-01

Read the full passage →